Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Corticosteroids for AECOPD with High Eosinophils
NCT05059873Phase 4Terminated
- Sponsor
- Capital Medical University
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in chronic obstructive pulmonary disease (COPD), sponsored by Capital Medical University. Started Mar 2023; status: terminated.
02
Drugs
prednisone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05059873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059873.